Bisphosphonates are the
most common medications prescribed for osteoporosis treatment. These include:
·
Alendronate (Fosamax)
·
Risedronate (Actonel)
·
Ibandronate (Boniva)
·
Zoledronic acid (Reclast)
Hormones, such as
estrogen, can play a role in osteoporosis prevention and treatment. However,
there has been some concern about potential side effects tied to the use of
hormone therapy. Current recommendations say to use the lowest dose of hormones
for the shortest period of time.
Still, women who have
reasons — such as menopausal symptoms — to consider using hormones can weigh
the benefit of improved bone health into their decision.
Some hormonelike
medications also are approved for preventing and treating osteoporosis, such as
raloxifene (Evista).
Denosumab (Prolia, Xgeva)
is a newer medication shown to reduce the risk of osteoporotic fracture in
women and men. Unrelated to bisphosphonates, denosumab might be used in people
who can't take a bisphosphonate, such as some people with reduced kidney
function.
Teriparatide (Forteo) is
typically reserved for men and postmenopausal women who have very low bone
density, who have had fractures or whose osteoporosis is caused by steroid
medication. Teriparatide has the potential to rebuild bone.
Abaloparatide (Tymlos) is
the newest osteoporosis medication. Like teriparatide, it has the potential to
rebuild bone. In a research trial comparing these two treatments, abaloparatide
appeared to be as effective as teriparatide but was less likely to cause an
excess of calcium.
For more information please search for the books "The Theory of Autoimmunity" and "Rebellious Thoughts about Osteoorosis" by Tanya G. Guleria in amazon.com
ReplyDelete